This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

ChinaBio™ Partnering Forum
April 28–29, 2026
Kerry Hotel Pudong, Shanghai, ChinaMay 6–7, 2026 - Digital Partnering

David Cristina
Principal at Vesalius Biocapital Partners
Speaker

Profile

David Cristina is a Principal at Vesalius Biocapital Partners, a European venture capital firm focused on life sciences, where he leads investment activities across biotech and digital health. He has deep experience in evaluating and supporting early-to-growth stage companies across Europe and internationally.

Prior to Vesalius, David held senior roles at Fosun, where he worked at the intersection of European and Chinese life sciences ecosystems during a pivotal period of globalisation in clinical development. This background gives him a distinctive perspective on cross-border deal-making, clinical execution, and the strategic considerations for companies building global programmes.

David brings a scientist's rigor to venture investing, holding a PhD in life sciences. He is particularly focused on companies developing innovative therapeutics and technologies with a clear path to global markets.


Agenda Sessions

  • Delivering Trials that Travel: CRO, Site and Execution Strategies in China

    15:30

At this event